CinoCore Health
June 18, 2025
Company Presentation
AI and Digital Health
154
CinoCore provides Agentic AI solutions to clinicians that accelerate their clincial research, improve efficiency of patient management and aids on clinical decision with most up-to-date evidences.
Company HQ City:
Shanghai
Company HQ State:
Shanghai
Company HQ Country:
China
Year Founded:
2022
Lead Product in Development:
Oncology Digital Therapeutics (Approved and Commercialized)
Clinical research AI agent (Developed and Deployed)
MDT co-pilot (Clinically Validated)
CEO
CHEN KAISHEN
Development Phase of Lead Product
NDA Preparation/In Review
What is your next catalyst (value inflection) update?
Q4 2025
Website
www.cinocore.com
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}